Freeman Chris (CIK 1871615) reported 53 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy GH (1,928 shares), Buy GH (1,667 shares), Buy GH (2,526 shares), Buy GH (1,293 shares), Sell GH (3,141 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,928 | $0 |
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,667 | $0 |
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 2,526 | $0 |
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,293 | $0 |
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 3,141 | $536,389 |
| 2026-06-16 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,402 | $0 |
| 2026-06-16 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 594 | $77,113 |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,929 | $0 |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,667 | $0 |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 2,526 | $0 |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 5,091 | $0 |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 4,750 | $432,962 |
| 2026-03-17 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 15,426 | $0 |
| 2026-03-17 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,402 | $0 |
| 2026-03-17 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 7,127 | $609,287 |
| 2026-01-05 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,928 | $0 |
| 2026-01-05 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 15,428 | $0 |
| 2026-01-05 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,667 | $0 |
| 2026-01-05 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 5,688 | $0 |
| 2026-01-05 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 2,526 | $0 |
| 2026-01-05 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 10,162 | $1.0M |
| 2025-12-17 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,402 | $0 |
| 2025-12-17 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 594 | $60,986 |
| 2025-12-08 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 478 | $48,484 |
| 2025-12-08 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 744 | $76,119 |
Source: SEC Form 4 filings · as of 2026-07-02